1061 related articles for article (PubMed ID: 10191203)
1. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
2. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts.
Chandran B; Bloomer C; Chan SR; Zhu L; Goldstein E; Horvat R
Virology; 1998 Sep; 249(1):140-9. PubMed ID: 9740785
[TBL] [Abstract][Full Text] [Related]
4. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
5. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.
Kellam P; Boshoff C; Whitby D; Matthews S; Weiss RA; Talbot SJ
J Hum Virol; 1997; 1(1):19-29. PubMed ID: 10195227
[TBL] [Abstract][Full Text] [Related]
6. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.
Biggar RJ; Engels EA; Whitby D; Kedes DH; Goedert JJ
J Infect Dis; 2003 Jan; 187(1):12-8. PubMed ID: 12508141
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.
Katano H; Sato Y; Kurata T; Mori S; Sata T
Virology; 2000 Apr; 269(2):335-44. PubMed ID: 10753712
[TBL] [Abstract][Full Text] [Related]
9. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
Caterino-de-Araujo A; Magri MC; Manuel RC
J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serologic assays for detection of antibodies against human herpesvirus 8.
Corchero JL; Mar EC; Spira TJ; Pellett PE; Inoue N
Clin Diagn Lab Immunol; 2001 Sep; 8(5):913-21. PubMed ID: 11527803
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
13. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
Kedes DH; Lagunoff M; Renne R; Ganem D
J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.
Chohan BH; Taylor H; Obrigewitch R; Lavreys L; Richardson BA; Mandaliya KN; Bwayo JJ; Kreiss JK; Morrow RA
J Clin Virol; 2004 Jun; 30(2):137-44. PubMed ID: 15125869
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8.
Lang D; Hinderer W; Rothe M; Sonneborn HH; Neipel F; Raab M; Rabenau H; Masquelier B; Fleury H
Virology; 1999 Jul; 260(1):47-54. PubMed ID: 10405355
[TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies directed against the immunogenic glycoprotein K8.1 of human herpesvirus 8.
Lang D; Birkmann A; Neipel F; Hinderer W; Rothe M; Ernst M; Sonneborn HH
Hybridoma; 2000 Aug; 19(4):287-95. PubMed ID: 11001401
[TBL] [Abstract][Full Text] [Related]
18. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1.
Raab MS; Albrecht JC; Birkmann A; Yağuboğlu S; Lang D; Fleckenstein B; Neipel F
J Virol; 1998 Aug; 72(8):6725-31. PubMed ID: 9658120
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
Szalai E; Gerlei Z; Szlávik J; Szládek G; Patel R; Hunyadi J; Gergely L; Juhász A
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):265-8. PubMed ID: 15681157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
